Challenging the Monogenic View: Genetic Diseases More Complex Than Assumed
New research suggests that many genetic diseases, including certain retinal conditions, are more complex than previously understood, challenging the long-held scientific assumption that single gene mutations are solely responsible. Large-scale population studies, which include genetic data from healthy individuals, reveal that many healthy people carry gene variants previously linked directly to disease without developing symptoms. This evolving understanding has significant implications for genetic counseling, risk assessment, and the development of gene therapies.
Shifting Understanding of Genetic Inheritance
For decades, scientists identified genetic mutations believed to be the sole cause of specific diseases. This traditional view, rooted in Mendelian genetics, categorized conditions as 'monogenic' if thought to be caused by a single gene (e.g., Tay-Sachs disease, often considered to have 100% penetrance) or 'polygenic' if involving multiple genes and environmental factors (e.g., Crohn's disease, schizophrenia).
Professor Caroline Wright of the University of Exeter notes that the assumption of a single genetic cause being both necessary and sufficient for a disease is often inaccurate.
The likelihood of a genotype manifesting as a particular trait is known as 'penetrance.' New findings indicate that many rare diseases once classified as monogenic behave more like polygenic conditions, with variable penetrance.
Insights from Population-Based Genetic Data
This shift in understanding is largely attributed to the development of vast genetic databases compiled from healthy populations, such as the U.S. National Institutes of Health All of Us cohort and the U.K. Biobank. Previously, research was often limited to patient samples due to high sequencing costs, leading to 'ascertainment bias' where gene variants appeared more causative than they were because their presence in healthy individuals was not widely assessed.
Dr. Eric Pierce and Dr. Elizabeth Rossin conducted studies examining these databases for 167 gene variants previously associated with severe vision loss in inherited retinal degenerations. Their findings indicate that individuals carrying these specific variants experienced vision loss in less than 30% of cases. This suggests that other genetic or environmental factors influence disease manifestation in the remaining 70% of carriers.
Re-evaluated Genetic Conditions
Similar patterns of reduced penetrance have been observed across various conditions:
- Thyroid Cancer: Genetic variants linked to thyroid cancer in 95% of clinical populations led to the disease in an estimated 2% to 19% of the general population.
- Osteogenesis Imperfecta (Brittle Bone Disease): Variants believed to cause this condition in nearly 100% of cases were found to do so in approximately 21% to 40% of carriers in the general population.
- Similar observations have been made for rare childhood eye cancer, mitochondrial diseases, inherited forms of diabetes, and ovarian insufficiency. Professor Anna Murray noted that many genes involved in conditions like ovarian insufficiency often have multiple roles and interactions.
Conversely, some population studies have revealed higher-than-expected genetic risks. For example, research by Michael Hayden's team found that approximately 1 in 400 people carry gene repeats (36-39 repeats) associated with Huntington's disease, placing them at an elevated risk, although additional genetic variants can further influence disease onset.
Implications for Patient Care and Future Treatments
This evolving understanding of genetic risk is important for:
- Genetic Counseling: It allows for more accurate individual risk assessments for patients and prospective parents, potentially indicating a lower personal risk than previously suggested by studies focused solely on affected populations.
- IVF Embryo Screening: It can offer more precise risk assessments for parents considering embryo implantation.
- Gene Therapy: The insights can help refine treatments by predicting which individuals might respond best and identifying new therapeutic targets based on additional genetic factors.
- The research aims to improve preventative and early treatment strategies, particularly for degenerative diseases of the brain and eye, where early intervention can prevent irreversible damage.
Researchers are actively pursuing global collaborations to further investigate the complex genetic modifiers influencing disease risk and manifestation.